Analysts Set Context Therapeutics Inc. (NASDAQ:CNTX) Price Target at $5.40
Context Therapeutics Inc. (NASDAQ:CNTX – Get Free Report) has been assigned an average recommendation of “Buy” from the five analysts that are covering the firm, Marketbeat reports. Four research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month target price among […]
Context Therapeutics Inc. (NASDAQ:CNTX – Get Free Report) has been assigned an average recommendation of “Buy” from the five analysts that are covering the firm, Marketbeat reports. Four research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month target price among […]
